[1]Thomas LE, Winston J, Rad E, et al. Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours[J]. Hum Genomics, 2015, 9(3): 15-28．
[2]Theos A, Korf BR, American College of Physicians, et al. Pathophysiology of neurofibromatosis type Ⅰ[J]． Ann Intern Med, 2006, 144(11): 842-849．
[3]Slaibi B, Daher JG, Da Fonseca GG, et al. Clinical and radiological repercussions of plexiform neurofibroma in the pelvic region[J]． Radiol Bras, 2014, 47(5): 326-328．
[4]Mautner VF, Friedrich RE, von Deimling A, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma[J]． Neuroradiology, 2003, 45(9): 618-625．
[5]Waggoner DJ, Towbin J, Gottesman G, et al. Clinic-based study of plexiform neurofibromas in neurofibromatosis[J]. Am J Med Genet, 2000, 92(2): 132-135．
[6]李跃明，黄飚． 丛状神经纤维瘤生长方式的MRI分析[J]． 中华放射学杂志，2008，42（6）：657-659．
[7]张雪哲，洪闻，王武，等． 下肢神经源性肿瘤的MRI表现[J]． 中华放射学杂志，2003，37（7）：626-628．
[8]韩月东. 软组织磁共振诊断学[M]． 北京：人民军医出版社，2006：168-212．
[9]朱玉春，王建良，吴志娟，等． 侵袭型丛状神经纤维瘤病1例[J]． 中国临床医学影像杂志，2012，23（6）：451-452．
[10]Lim C, Kwon K, Lee K, et al. Plexiform neurofibroma treated with pharmacopuncture[J]． J Pharmacopuncture, 2014, 17(3): 74-77．